Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E-W Radue

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis GroupL Kappos, D Moeri, E W Radue, et al.
Neuroscience and Biobehavioral Reviews|February 11, 2010
Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysisR Smieskova, P Fusar-Poli, P Allen, et al.
Neurology|November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MSJ Kuhle, R Gosert, R Bühler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
Radiological findings in individuals at high risk of psychosisS J Borgwardt, E-W Radue, K Götz, et al.
Neurology|December 31, 1997
Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosisF Barkhof, M Filippi, J H van Waesberghe, et al.
European Journal of Neurology|December 25, 2015
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosisÖ Yaldizli, I-K Penner, T Yonekawa, et al.
Neurology|June 10, 2009
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1aR A Rudick, A Pace, M R S Rani, et al.
AJNR. American Journal of Neuroradiology|November 14, 2015
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple SclerosisA Traboulsee, J H Simon, L Stone, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, W Roser, et al.
Neurology|September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINELP A Calabresi, G Giovannoni, C Confavreux, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis GroupL Kappos, D Moeri, E W Radue, et al.
Neuroscience and Biobehavioral Reviews|February 11, 2010
Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysisR Smieskova, P Fusar-Poli, P Allen, et al.
Neurology|November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MSJ Kuhle, R Gosert, R Bühler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
Radiological findings in individuals at high risk of psychosisS J Borgwardt, E-W Radue, K Götz, et al.
Neurology|December 31, 1997
Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosisF Barkhof, M Filippi, J H van Waesberghe, et al.
European Journal of Neurology|December 25, 2015
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosisÖ Yaldizli, I-K Penner, T Yonekawa, et al.
Neurology|June 10, 2009
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1aR A Rudick, A Pace, M R S Rani, et al.
AJNR. American Journal of Neuroradiology|November 14, 2015
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple SclerosisA Traboulsee, J H Simon, L Stone, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, W Roser, et al.
Neurology|September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINELP A Calabresi, G Giovannoni, C Confavreux, et al.
Pageof 7